Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) saw a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 680,900 shares, a growth of 15.9% from the May 15th total of 587,600 shares. Based on an average daily volume of 695,200 shares, the days-to-cover ratio […]